treatment news

Half of people with HIV can start treatment on same day

Half of those attending HIV clinics in South Africa and Kenya were eligible to start HIV treatment after simple checks that could be performed by any healthcare worker, and same-day treatment initiation modestly improved the uptake of antiretroviral therapy (ART),...

read more

Two thirds prefer self-testing over self-sampling

Given a choice between free online self-testing and online self-sampling for HIV, the majority of people chose self-testing. But self-sampling was chosen by a substantial minority, according to a UK pilot study recently published in the International Journal of STD...

read more

Oral cabotegravir and rilpivirine still effective at 312 weeks

A combination of two once-daily oral antiretrovirals, cabotegravir and rilpivirine, maintained HIV suppression for 5.5 years after a six-month lead-in period, according to a presentation at the recent IDWeek 2019 conference in Washington, DC. Dr David Margolis of ViiV...

read more

Rapid treatment start doesn’t benefit all

People who started HIV treatment in the first few weeks after being diagnosed with HIV were significantly less likely to be retained in care a year later, a large French study has reported. French researchers associated with the Dat’AIDS study group, reporting their...

read more

Do integrase inhibitors increase the risk of diabetes?

People who started antiretroviral therapy (ART) with a regimen that included an integrase inhibitor were more likely to develop diabetes mellitus, although this increased risk differed between specific drugs, researchers reported at the IDWeek 2019 conference in...

read more